title: [Menopause in a diabetic].
abstract: With the growing incidence of both type 1 and type 2 diabetes, the number of diabetic women of menopause age is on the rise in our country. The risk of osteoporosis seems to be significant especially in type 1 diabetic patients. Similarly to other women, a diabetic woman can receive palliative treatment for her menopausal symptoms. Transdermally administered estrogen is favourable in the therapy. The possible contraindications of hormone therapy must, however, be accurately surveyed along with an assessment and treatment of risk factors for cardiovascular diseases prior to initiation of hormone therapy.
authors.affiliation: Helsingin yliopisto, kliininen laitos, yleislääketieteen ja perusterveydenhuollon osasto.
authors.forename: Lena
authors.initials: L
authors.lastname: Sjöberg-Tuominen
authors.forename: Aila
authors.initials: A
authors.lastname: Tiitinen
mesh_terms: D002318:Cardiovascular Diseases / Q000503:physiopathology / Q000517:prevention & control; D000075202:Contraindications; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology / Q000503:physiopathology* / Q000628:therapy; D015914:Estrogen Replacement Therapy / Q000379:methods; D005260:Female; D006801:Humans; D015994:Incidence; D008593:Menopause / Q000502:physiology*; D015663:Osteoporosis, Postmenopausal / Q000503:physiopathology / Q000517:prevention & control; D010166:Palliative Care; D012307:Risk Factors